• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Allosteric activation of plasma membrane receptors--physiological implications and structural origins.

作者信息

Conigrave Arthur D, Franks Alison H

机构信息

School of Molecular and Microbial Biosciences, University of Sydney, NSW 2006, Australia.

出版信息

Prog Biophys Mol Biol. 2003 Apr;81(3):219-40. doi: 10.1016/s0079-6107(03)00020-8.

DOI:10.1016/s0079-6107(03)00020-8
PMID:12732263
Abstract

Allosteric modulation of receptors has physiological not just pharmacological significance. Thus, the chemical context in which an agonist signal is received can have a major impact on the nature of the physiological response by modifying receptor sensitivity and/or maximal activity-even the nature of the signalling response. In addition, recognising that an endogenous activator is the allosteric modulator of a known receptor, rather than the agonist of a novel receptor, has the potential to solve, in dramatic fashion, key physiological questions. What is an allosteric modulator and why are allosteric effects on receptors so diverse and frequently complex? What is the scope of allosteric effects? Can the existence of endogenous modulators be predicted from a receptor's amino acid sequence? How should screening for endogenous allosteric modulators be undertaken? These questions form the framework of this mini-review on physiological and structural aspects of receptor allostery.

摘要

相似文献

1
Allosteric activation of plasma membrane receptors--physiological implications and structural origins.
Prog Biophys Mol Biol. 2003 Apr;81(3):219-40. doi: 10.1016/s0079-6107(03)00020-8.
2
Allosteric modulation of G protein-coupled receptors.G蛋白偶联受体的变构调节
Annu Rev Pharmacol Toxicol. 2007;47:1-51. doi: 10.1146/annurev.pharmtox.47.120505.105159.
3
Allosteric modulation of metabotropic glutamate receptors: structural insights and therapeutic potential.变构调节代谢型谷氨酸受体:结构见解与治疗潜力。
Neuropharmacology. 2011 Jan;60(1):66-81. doi: 10.1016/j.neuropharm.2010.07.007. Epub 2010 Jul 14.
4
Structural Connection between Activation Microswitch and Allosteric Sodium Site in GPCR Signaling.激动型微开关与 GPCR 信号中的变构钠离子位点的结构连接。
Structure. 2018 Feb 6;26(2):259-269.e5. doi: 10.1016/j.str.2017.12.013. Epub 2018 Jan 27.
5
Asymmetric functioning of dimeric metabotropic glutamate receptors disclosed by positive allosteric modulators.正变构调节剂揭示的二聚体代谢型谷氨酸受体的不对称功能
J Biol Chem. 2005 Jul 1;280(26):24380-5. doi: 10.1074/jbc.M502642200. Epub 2005 Apr 29.
6
Chimeric Glutamate Receptor Subunits Reveal the Transmembrane Domain Is Sufficient for NMDA Receptor Pore Properties but Some Positive Allosteric Modulators Require Additional Domains.嵌合型谷氨酸受体亚基揭示跨膜结构域足以决定NMDA受体的孔道特性,但某些正性变构调节剂需要其他结构域。
J Neurosci. 2016 Aug 24;36(34):8815-25. doi: 10.1523/JNEUROSCI.0345-16.2016.
7
Mapping Cannabinoid 1 Receptor Allosteric Site(s): Critical Molecular Determinant and Signaling Profile of GAT100, a Novel, Potent, and Irreversibly Binding Probe.绘制大麻素1受体变构位点:新型、强效且不可逆结合探针GAT100的关键分子决定因素和信号特征
ACS Chem Neurosci. 2016 Jun 15;7(6):776-98. doi: 10.1021/acschemneuro.6b00041. Epub 2016 Apr 25.
8
Positive and negative allosteric modulation of metabotropic glutamate receptors: emerging therapeutic potential.代谢型谷氨酸受体的正性和负性变构调节:新出现的治疗潜力。
Pharmacol Ther. 2004 Dec;104(3):233-44. doi: 10.1016/j.pharmthera.2004.08.010.
9
Ago-allosteric modulation and other types of allostery in dimeric 7TM receptors.二聚体7次跨膜受体中的前变构调节及其他变构类型
J Recept Signal Transduct Res. 2006;26(1-2):107-28. doi: 10.1080/10799890600567570.
10
Allosteric modulation of G protein-coupled receptors.G蛋白偶联受体的变构调节
Curr Pharm Des. 2004;10(17):2003-13. doi: 10.2174/1381612043384303.

引用本文的文献

1
Acute-serum amyloid A and A-SAA-derived peptides as formyl peptide receptor (FPR) 2 ligands.急性血清淀粉样蛋白 A 和 A-SAA 衍生肽作为甲酰肽受体 (FPR)2 的配体。
Front Endocrinol (Lausanne). 2023 Feb 3;14:1119227. doi: 10.3389/fendo.2023.1119227. eCollection 2023.
2
A case study comparing quantitative stability-flexibility relationships across five metallo-β-lactamases highlighting differences within NDM-1.一项案例研究,比较了五种金属β-内酰胺酶的定量稳定性-灵活性关系,突出了新德里金属β-内酰胺酶1(NDM-1)内部的差异。
Methods Mol Biol. 2014;1084:227-38. doi: 10.1007/978-1-62703-658-0_12.
3
Endogenous positive allosteric modulation of GABA(A) receptors by diazepam binding inhibitor.
地西泮结合抑制剂对内源性正变构调节 GABA(A) 受体。
Neuron. 2013 Jun 19;78(6):1063-74. doi: 10.1016/j.neuron.2013.04.026. Epub 2013 May 30.
4
Characterization of human and rodent native and recombinant adenosine A(2B) receptors by radioligand binding studies.通过放射性配体结合研究对人和啮齿动物天然和重组的腺苷 A(2B)受体进行表征。
Purinergic Signal. 2006 Sep;2(3):559-71. doi: 10.1007/s11302-006-9012-4. Epub 2006 Jul 8.
5
Targeting opioid receptor heterodimers: strategies for screening and drug development.靶向阿片受体异二聚体:筛选与药物开发策略
AAPS J. 2006 Mar 10;8(1):E153-9. doi: 10.1208/aapsj080118.